Is helicobacter pylori infection a risk factor for coronary heart disease?

Mehran Rogha, Marjan Nikvarz, Zahra Pourmoghaddas, Keivan Shirneshan, Davood Dadkhah, Masoud Pourmoghaddas, Mehran Rogha, Marjan Nikvarz, Zahra Pourmoghaddas, Keivan Shirneshan, Davood Dadkhah, Masoud Pourmoghaddas

Abstract

Background: There is still controversy about association of Helicobacter pylori (H. pylori) infection with coronary heart disease (CHD). This study designed to evaluate this association in a sample of Iranians Population.

Methods: Medical and drug history as well as fasting blood samples of 112 consecutive patients who were candidate for coronary angiography were taken on catheterization day. Fasting blood samples were used to measure C-reactive protein (CRP), anti H. pylori immunoglobulin G (anti H. pylori IgG) and interlukine-6 (IL6). According to angiography reports, participants were divided into patients with (n = 62) or without CHD (n = 43). To compare the association between H. pylori infection with CHD, multivariate logistic regression tests were used by adjusting sex and age, age and sex plus history of diabetes mellitus (DM), Dyslipidemia (DLP), and/or hypertension (HTN), CRP status and IL-6 level.

Results: Sixty two patients with CHD and 43 participants without CHD were enrolled in the present study. The mean ages of patients with and without CHD were 62.4 261 9.5 and 59.0 261 10.5 years respectively. Multivariate logistic regression analysis after adjusting for history of DM and/or DLP and/or HTN plus CRP status and IL-6 level showed significant association of H. pylori infection with CHD (OR 3.18, 95%CI 1.08-9.40).

Conclusion: H. pylori infection is one of the probable risk factors for CHD independent of history of DM, DLP, HTN, CRP status and IL-6 level.

Keywords: Angiography; Coronary Heart Disease; Helicobacter Pylori.

References

    1. Tiong AY, Brieger D. Inflammation and coronaryartery disease. Am Heart J. 2005;150(1):11–8.
    1. Onat A, Sari I, Hergenc G, Yazici M, Uyarel H, Can G, et al. Predictors of abdominal obesity and highsusceptibility of cardiometabolic risk to itsincrements among Turkish women: a prospectivepopulation-based study. Metabolism. 2007;56(3):348–56.
    1. Ridker PM. Evaluating novel cardiovascular riskfactors: can we better predict heart attacks? Ann Intern Med. 1999;130(11):933–7.
    1. Fong IW. Emerging relations between infectiousdiseases and coronary artery disease andatherosclerosis. CMAJ. 2000;163(1):49–56.
    1. Saijo Y, Utsugi M, Yoshioka E, Horikawa N, Sato T, Gong Y, et al. Relationship of Helicobacter pyloriinfection to arterial stiffness in Japanese subjects. Hypertens Res. 2005;28(4):283–92.
    1. Prasad A, Zhu J, Halcox JP, Waclawiw MA, Epstein SE, Quyyumi AA. Predisposition to atherosclerosisby infections: role of endothelial dysfunction. Circulation. 2002;106(2):184–90.
    1. Taylor DN, Blaser MJ. The epidemiology ofHelicobacter pylori infection. Epidemiol Rev. 1991;13:42–59.
    1. Fagoonee S, De AC, Elia C, Silvano S, Oliaro E, Rizzetto M, et al. Potential link between Helicobacterpylori and ischemic heart disease: does the bacteriumelicit thrombosis? Minerva Med. 2010;101(2):121–5.
    1. Tunca A, Turkay C, Tekin O, Kargili A, Erbayrak M. Is Helicobacter pylori infection a risk factor formigraine? A case-control study. Acta Neurol Belg. 2004;104(4):161–4.
    1. Jin SW, Her SH, Lee JM, Yoon HJ, Moon SJ, Kim PJ, et al. The association between current Helicobacter pylori infection and coronary arterydisease. Korean J Intern Med. 2007;22(3):152–6.
    1. Danesh J, Youngman L, Clark S, Parish S, Peto R, Collins R. Helicobacter pylori infection and earlyonset myocardial infarction: case-control and siblingpairs study. BMJ. 1999;319(7218):1157–62.
    1. Lee SY, Kim DK, Son HJ, Lee JH, Kim YH, Kim JJ, et al. The impact of Helicobacter pylori infection oncoronary heart disease in a Korean population. Korean J Gastroenterol. 2004;44(4):193–8.
    1. Biagi P, Fabbrini D, Bocchini S. Seroprevalence ofHelicobacter pylori infection in a group ofhospitalized geriatric patients. Panminerva Med. 2000;42(3):183–6.
    1. Bush CA, VanFossen DB, Kolibash AJ, Magorien RD, Bacon JP, Ansel GM, et al. Cardiaccatheterization and coronary angiography using 5French preformed (Judkins) catheters from thepercutaneous right brachial approach: a comparativeanalysis with the femoral approach. Cathet Cardiovasc Diagn. 1993;29(4):267–72.
    1. Whincup P, Danesh J, Walker M, Lennon L, Thomson A, Appleby P, et al. Prospective study ofpotentially virulent strains of Helicobacter pylori andcoronary heart disease in middle-aged men. Circulation. 2000;101(14):1647–52.
    1. Khodaii Z, Vakili H, Ghaderian SM, Najar RA, Panah AS. Association of Helicobacter pyloriinfection with acute myocardial infarction. Coron Artery Dis. 2011;22(1):6–11.
    1. Migneco A, Ojetti V, Specchia L, Franceschi F, Candelli M, Mettimano M, et al. Eradication ofHelicobacter pylori infection improves blood pressurevalues in patients affected by hypertension. Helicobacter. 2003;8(6):585–9.
    1. Jia EZ, Zhao FJ, Hao B, Zhu TB, Wang LS, Chen B, et al. Helicobacter pylori infection is associated withdecreased serum levels of high density lipoprotein,but not with the severity of coronary atherosclerosis. Lipids Health Dis. 2009;8:59.
    1. Chimienti G, Russo F, Lamanuzzi BL, Nardulli M, Messa C, Di LA, et al. Helicobacter pylori isassociated with modified lipid profile: impact onLipoprotein(a). Clin Biochem. 2003;36(5):359–65.
    1. Rahman A, Cope MB, Sarker SH, Garvey T, Chadhury H, Khaled M. Helicobacter pylori infectionand inflammation implications for pathophysiologyof diabetes mellitus and coronary heart disease. J life Sci. 2009;1(1):45–50.
    1. Ishida Y, Suzuki K, Taki K, Niwa T, Kurotsuchi S, Ando H, et al. Significant association betweenHelicobacter pylori infection and serum C-reactiveprotein. Int J Med Sci. 2008;5(4):224–9.
    1. Hisatsune J, Nakayama M, Isomoto H, Kurazono H, Mukaida N, Mukhopadhyay AK, et al. Molecularcharacterization of Helicobacter pylori VacAinduction of IL-8 in U937 cells reveals a prominentrole for p38MAPK in activating transcription factor-2, cAMP response element binding protein, and NFkappaBactivation. J Immunol. 2008;180(7):5017–27.
    1. Kowalski M, Pawlik M, Konturek JW, Konturek SJ. Helicobacter pylori infection in coronary artery disease. J Physiol Pharmacol. 2006;57 (Suppl 3):101.

Source: PubMed

Patrocinadores y Colaboradores

Condiciones médicas

Intervenciones de drogas

3
Suscribir